|
|
|
Elsevier Business Intelligence, Hyatt Regency Boston, MA
June 24-26, 2013
Join us in Boston this June and Gain Critical Perspective on the Challenges and Opportunities Facing All Players in the Evolving Global Medical Device Market
Elsevier Business Intelligence, publisher of the "The Gray Sheet," IN VIVO, START-UP and Medtech Insight, is pleased to announce Investment In Innovation (IN3) Medical Device 360° Boston 2013. In today's increasingly complex, globally driven healthcare environment, your business requires up-to-the-minute market expertise on all the critical factors impacting your success. EBI, as a leader in the field of healthcare industry data and analysis, gives medical technology executives a full 360° view of their market, opportunities and challenges. The upcoming IN³ Medical Device 360° Boston 2013 conference, marking EBI's 13th year of successful and highly anticipated investment and partnering events, with IN³ events held in Boston each of these years, is a true reflection of this 360° spirit. Building on the success of past IN³ events in Dublin, London, Paris, Rome, Brussels, and across the U.S., this must-attend event, being held in the epicenter of device innovation and investment on the East Coast, will bring together development- to commercial-stage device start-ups from around the world seeking funding or strategic partnership with top-tier venture capital and strategic decision makers. The two-day conference will also feature international industry experts examining the most pressing issues facing our global industry in 2013 and beyond, via a variety of financing, business development, clinical/regulatory, reimbursement, and emerging market panel discussions and presentations, and networking sessions.
|
|
|
|
|
|
Organized by:
|
|
Elsevier Business Intelligence |
|
Invited Speakers:
|
|
Who Attends? - Presidents, Principals, CEOs, CTOs, COOs, CMOs
- Founders, Board Leaders, Chairpersons
- Venture Partners, Senior Investors, Private Equity, Angel Investors
- VPs/Directors of Strategic Planning, Business Development/Analysis, Marketing, New Technology, Acquisitions, R&D, Sales
From These Types of Companies - Established, large device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
- VCs, private equity, investment firms/consultant, and investment banks.
- Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships
|
|
|
|
|
|
Deadline for Abstracts:
|
|
To be updated
|
|
|
|
|
|
Registration:
|
|
For detailed registration information, please contact:
|
|
E-mail:
|
|
k.kennedy@elsevier.com
|
|
|
|
|
|
|
|